Literature DB >> 9228292

Synthetic peptide-based activators of the proteasome.

S Wilk1, W E Chen.   

Abstract

The development of small molecule peptide-based activators of the 20S proteasome or multicatalytic proteinase complex was initiated. The enhancement of antigen presentation by transfection of the protein activator PA28alpha into a mouse fibroblast cell line [10] supports the potential use of small molecule activators in stimulating the immune response. Four classes of peptide-based activators were synthesized, i.e. peptidyl alcohols, esters, p-nitroanilides and nitriles. These compounds markedly and reversibly stimulated the hydrolysis of suc-LLVY-MCA, Z-LLE-NA and Z-GPALG-p-aminobenzoate as well as hydrolysis of the decapeptide angiotensin I. Stimulation was due to a decrease in the Km and increase in the Vmax of the substrate. In general, the EC50 for activation ranged from 50-150 mM and maximal stimulation varied from 3 to 15 fold depending on the activity measured. Z-IE(Ot-Bu)AL-p-nitroanilide, a proteasome substrate, markedly stimulated the hydrolysis of Z-GPALG-pAB by binding to a saturable high affinity site distinct from its binding site as substrate. Since all effective activators contain hydrophobic groups in positions P1-P5, low aqueous solubility is a limitation of these compounds. Competition experiments suggest that these activators bind to the same site as PA28.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9228292     DOI: 10.1023/a:1006851428691

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.316


  24 in total

1.  Kinetic characterization of the chymotryptic activity of the 20S proteasome.

Authors:  R L Stein; F Melandri; L Dick
Journal:  Biochemistry       Date:  1996-04-02       Impact factor: 3.162

2.  In vivo assembly of the proteasomal complexes, implications for antigen processing.

Authors:  Y Yang; K Früh; K Ahn; P A Peterson
Journal:  J Biol Chem       Date:  1995-11-17       Impact factor: 5.157

3.  PA28, an activator of the 20 S proteasome, is inactivated by proteolytic modification at its carboxyl terminus.

Authors:  C P Ma; P J Willy; C A Slaughter; G N DeMartino
Journal:  J Biol Chem       Date:  1993-10-25       Impact factor: 5.157

4.  Molecular cloning and expression of a gamma-interferon-inducible activator of the multicatalytic protease.

Authors:  C Realini; W Dubiel; G Pratt; K Ferrell; M Rechsteiner
Journal:  J Biol Chem       Date:  1994-08-12       Impact factor: 5.157

5.  Evidence that pituitary cation-sensitive neutral endopeptidase is a multicatalytic protease complex.

Authors:  S Wilk; M Orlowski
Journal:  J Neurochem       Date:  1983-03       Impact factor: 5.372

6.  A multicatalytic protease complex from pituitary that forms enkephalin and enkephalin containing peptides.

Authors:  M Orlowski; S Wilk
Journal:  Biochem Biophys Res Commun       Date:  1981-08-14       Impact factor: 3.575

7.  Activation of the multicatalytic proteinase from rat skeletal muscle by fatty acids or sodium dodecyl sulphate.

Authors:  B Dahlmann; M Rutschmann; L Kuehn; H Reinauer
Journal:  Biochem J       Date:  1985-05-15       Impact factor: 3.857

8.  Synthetic inhibitors of the multicatalytic proteinase complex (proteasome).

Authors:  S Wilk; M E Figueiredo-Pereira
Journal:  Enzyme Protein       Date:  1993

9.  Evidence for the presence of five distinct proteolytic components in the pituitary multicatalytic proteinase complex. Properties of two components cleaving bonds on the carboxyl side of branched chain and small neutral amino acids.

Authors:  M Orlowski; C Cardozo; C Michaud
Journal:  Biochemistry       Date:  1993-02-16       Impact factor: 3.162

10.  The proteasome subunit, C2, contains an important site for binding of the PA28 (11S) activator.

Authors:  M A Kania; G N Demartino; W Baumeister; A L Goldberg
Journal:  Eur J Biochem       Date:  1996-03-01
View more
  9 in total

Review 1.  Ubiquitin/proteasome pathway impairment in neurodegeneration: therapeutic implications.

Authors:  Qian Huang; Maria E Figueiredo-Pereira
Journal:  Apoptosis       Date:  2010-11       Impact factor: 4.677

2.  Establishment of a suite of assays that support the discovery of proteasome stimulators.

Authors:  Darci J Trader; Scott Simanski; Paige Dickson; Thomas Kodadek
Journal:  Biochim Biophys Acta Gen Subj       Date:  2017-01-05       Impact factor: 3.770

3.  The proteasome as a druggable target with multiple therapeutic potentialities: Cutting and non-cutting edges.

Authors:  G R Tundo; D Sbardella; A M Santoro; A Coletta; F Oddone; G Grasso; D Milardi; P M Lacal; S Marini; R Purrello; G Graziani; M Coletta
Journal:  Pharmacol Ther       Date:  2020-05-19       Impact factor: 12.310

4.  Functional interactions of HslV (ClpQ) with the ATPase HslU (ClpY).

Authors:  Ravishankar Ramachandran; Claudia Hartmann; Hyun Kyu Song; Robert Huber; Matthias Bochtler
Journal:  Proc Natl Acad Sci U S A       Date:  2002-05-28       Impact factor: 11.205

Review 5.  Proteasome regulators: activators and inhibitors.

Authors:  Li Huang; Chin Ho Chen
Journal:  Curr Med Chem       Date:  2009       Impact factor: 4.530

6.  Activation and inhibition of the proteasome by betulinic acid and its derivatives.

Authors:  Li Huang; Phong Ho; Chin-Ho Chen
Journal:  FEBS Lett       Date:  2007-09-24       Impact factor: 4.124

Review 7.  Role of proteasomes in disease.

Authors:  Burkhardt Dahlmann
Journal:  BMC Biochem       Date:  2007-11-22       Impact factor: 4.059

Review 8.  Neuronal death in Alzheimer's disease and therapeutic opportunities.

Authors:  Rossen Donev; Martin Kolev; Bruno Millet; Johannes Thome
Journal:  J Cell Mol Med       Date:  2009-09-01       Impact factor: 5.310

9.  Proline- and Arginine-Rich Peptides as Flexible Allosteric Modulators of Human Proteasome Activity.

Authors:  Małgorzata Giżyńska; Julia Witkowska; Przemysław Karpowicz; Rafał Rostankowski; Estrella S Chocron; Andrew M Pickering; Pawel Osmulski; Maria Gaczynska; Elżbieta Jankowska
Journal:  J Med Chem       Date:  2018-12-03       Impact factor: 7.446

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.